114 related articles for article (PubMed ID: 2657629)
1. Acromegaly in an infant.
Blumberg DL; Sklar CA; David R; Rothenberg S; Bell J
Pediatrics; 1989 Jun; 83(6):998-1002. PubMed ID: 2657629
[TBL] [Abstract][Full Text] [Related]
2. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
[TBL] [Abstract][Full Text] [Related]
4. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
Wass JA
J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
[TBL] [Abstract][Full Text] [Related]
5. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma.
Bonert VS; Melmed S
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):408-12; quiz following 412. PubMed ID: 16932323
[TBL] [Abstract][Full Text] [Related]
7. The treatment of acromegaly by transsphenoidal surgery.
Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
[TBL] [Abstract][Full Text] [Related]
8. Somatomedin-C in active and successfully treated acromegaly.
Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly. Clinical and biochemical features in 500 patients.
Ezzat S; Forster MJ; Berchtold P; Redelmeier DA; Boerlin V; Harris AG
Medicine (Baltimore); 1994 Sep; 73(5):233-40. PubMed ID: 7934807
[TBL] [Abstract][Full Text] [Related]
10. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
Gradiser M; Matovinovic M; Vrkljan M
Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
[TBL] [Abstract][Full Text] [Related]
13. Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia.
Saeger W; Kant P; Caselitz J; Lüdecke DK
Pathol Res Pract; 1988 Feb; 183(1):17-24. PubMed ID: 3362748
[TBL] [Abstract][Full Text] [Related]
14. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases.
Haney AF; McCarty KS; Hammond CB
J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688
[TBL] [Abstract][Full Text] [Related]
15. [Acromegaly].
Morange I; Jaquet P
Rev Prat; 1996 Jun; 46(12):1482-5. PubMed ID: 8881161
[TBL] [Abstract][Full Text] [Related]
16. [What is the value of determining immunoreactive GHRH in acromegaly?].
Müller B; de Marco D; Bürgi U; Mullis PE
Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668
[TBL] [Abstract][Full Text] [Related]
17. Primary octreotide LAR therapy in GH-secreting pituitary adenoma.
Harinarayan CV
J Indian Med Assoc; 2004 May; 102(5):258, 260-1. PubMed ID: 15636029
[TBL] [Abstract][Full Text] [Related]
18. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone secreting adenoma with unusual extension: coexisting pituitary cyst and its clinical significance.
Saeki N; Sunada S; Tokunaga H; Hoshi S; Sunami K; Terano T; Yamaura A
J Clin Neurosci; 2000 Mar; 7(2):146-7. PubMed ID: 10844802
[TBL] [Abstract][Full Text] [Related]
20. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
